http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-092403-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12282739534358ece9af416546e3c727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9abbe1f20867e44dc33e63a6ac02120
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
filingDate 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-092403-A1
titleOfInvention POLYMERIC NANOPARTICULA OF FINASTERIDA AND MINOXIDIL, PREPARATION PROCESS, WATERPROOF SUSPENSION CONTAINING THE SAME, PHARMACEUTICAL COMPOSITION, AND ITS USE
abstract Claim 1: Polymeric nanoparticle characterized by comprising the active substances finasteride and minoxidil, said nanoparticle being formed from the preparation of an organic phase and an aqueous phase, wherein: (a) the organic phase comprises: (i) a hydrophobic polymer, (ii) a fixed oil, (iii) at least one lipophilic surfactant of low EHL, (iv) an organic solvent, (v) a co-solvent and (vi) finasteride, and (b) the aqueous phase it comprises: (vii) at least one hydrophilic surfactant, (viii) minoxidil, and (ix) water.
priorityDate 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415001522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408176977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135743713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 38.